Formation, Selective Encapsulation, and Tautomerization Control of Isoindolone Utilizing Guanidinium Sulfonate Frameworks
Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate (G4PYR) and bis (guanidinium) 1,5‐napthalene disulfonate (G2NDS) to catalyze the cyclization of 2‐cyanobenzamide (1) to isoindolone (2). Moreover, we demonstrate the remarkable selectivity of these guanidinium organosulfonate ho...
Saved in:
| Published in | Chemistry : a European journal Vol. 30; no. 33; pp. e202400957 - n/a |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Germany
Wiley Subscription Services, Inc
12.06.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate (G4PYR) and bis (guanidinium) 1,5‐napthalene disulfonate (G2NDS) to catalyze the cyclization of 2‐cyanobenzamide (1) to isoindolone (2). Moreover, we demonstrate the remarkable selectivity of these guanidinium organosulfonate hosts in encapsulating 2 over 1. By thoroughly investigating the intramolecular cyclization reaction, we determined that guanidinium and the organosulfonate moiety acts as the catalyst in this process. Additionally, 2 is selectively encapsulated, even in mixtures of other structurally similar heterocycles like indole. Furthermore, the tautomeric state of 2 (amino isoindolone (2–A) and imino isoindolinone forms (2–I)) can be controlled by utilizing different guanidinium organosulfonate frameworks.
Hydrogen bonding frameworks can do it all; catalysis, selective encapsulation, and control of tautomeric state. |
|---|---|
| AbstractList | Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate (G4PYR) and bis (guanidinium) 1,5‐napthalene disulfonate (G2NDS) to catalyze the cyclization of 2‐cyanobenzamide (1) to isoindolone (2). Moreover, we demonstrate the remarkable selectivity of these guanidinium organosulfonate hosts in encapsulating 2 over 1. By thoroughly investigating the intramolecular cyclization reaction, we determined that guanidinium and the organosulfonate moiety acts as the catalyst in this process. Additionally, 2 is selectively encapsulated, even in mixtures of other structurally similar heterocycles like indole. Furthermore, the tautomeric state of 2 (amino isoindolone (2–A) and imino isoindolinone forms (2–I)) can be controlled by utilizing different guanidinium organosulfonate frameworks. Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate (G4PYR) and bis (guanidinium) 1,5‐napthalene disulfonate (G2NDS) to catalyze the cyclization of 2‐cyanobenzamide (1) to isoindolone (2). Moreover, we demonstrate the remarkable selectivity of these guanidinium organosulfonate hosts in encapsulating 2 over 1. By thoroughly investigating the intramolecular cyclization reaction, we determined that guanidinium and the organosulfonate moiety acts as the catalyst in this process. Additionally, 2 is selectively encapsulated, even in mixtures of other structurally similar heterocycles like indole. Furthermore, the tautomeric state of 2 (amino isoindolone (2–A) and imino isoindolinone forms (2–I)) can be controlled by utilizing different guanidinium organosulfonate frameworks. Hydrogen bonding frameworks can do it all; catalysis, selective encapsulation, and control of tautomeric state. Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate (G PYR) and bis (guanidinium) 1,5-napthalene disulfonate (G NDS) to catalyze the cyclization of 2-cyanobenzamide (1) to isoindolone (2). Moreover, we demonstrate the remarkable selectivity of these guanidinium organosulfonate hosts in encapsulating 2 over 1. By thoroughly investigating the intramolecular cyclization reaction, we determined that guanidinium and the organosulfonate moiety acts as the catalyst in this process. Additionally, 2 is selectively encapsulated, even in mixtures of other structurally similar heterocycles like indole. Furthermore, the tautomeric state of 2 (amino isoindolone (2-A) and imino isoindolinone forms (2-I)) can be controlled by utilizing different guanidinium organosulfonate frameworks. Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate ( G 4 PYR ) and bis (guanidinium) 1,5‐napthalene disulfonate ( G 2 NDS ) to catalyze the cyclization of 2‐cyanobenzamide ( 1 ) to isoindolone ( 2 ). Moreover, we demonstrate the remarkable selectivity of these guanidinium organosulfonate hosts in encapsulating 2 over 1 . By thoroughly investigating the intramolecular cyclization reaction, we determined that guanidinium and the organosulfonate moiety acts as the catalyst in this process. Additionally, 2 is selectively encapsulated, even in mixtures of other structurally similar heterocycles like indole. Furthermore, the tautomeric state of 2 (amino isoindolone ( 2 – A ) and imino isoindolinone forms ( 2 – I )) can be controlled by utilizing different guanidinium organosulfonate frameworks. |
| Author | Chaudhry, Mohammad T. Newman, Justin A. Lee, Alfred Y. |
| Author_xml | – sequence: 1 givenname: Mohammad T. orcidid: 0000-0002-1482-388X surname: Chaudhry fullname: Chaudhry, Mohammad T. email: mohammad.chaudhry1@merck.com organization: Inc – sequence: 2 givenname: Justin A. orcidid: 0000-0002-2498-1259 surname: Newman fullname: Newman, Justin A. email: justin.newman@merck.com organization: Inc – sequence: 3 givenname: Alfred Y. orcidid: 0000-0003-3684-4101 surname: Lee fullname: Lee, Alfred Y. organization: Inc |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38608156$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUFPGzEQhS0EKiHttcfKUi89dFN7vWvvHqsoASQqDsB55dhjauq1U3sNCr--pkmp1EtPI8188_Rm3hk69sEDQu8pWVBC6i_qO4yLmtQNIX0rjtCMtjWtmODtMZqRvhEVb1l_is5SeiCF4Yy9Qaes46SjLZ-h3TrEUU42-M_4BhyoyT4CXnkltym7w0B6jW9lnsII0T7_buJl8FMMDgeDL1OwXgdXnOG7yTr7bP09Ps_SW229zSO-yc4ELyfA6yhHeArxR3qLTox0Cd4d6hzdrVe3y4vq6vr8cvn1qlKs7kTVGW6E5kpvjObA267WraYNbXq6ETWVxBBTcwBoVTlKaAOKc62aBqCRVCk2R5_2utsYfmZI0zDapMA56SHkNDDCuoYJ0XcF_fgP-hBy9MVdoTjvmKDlf3O02FMqhpQimGEb7SjjbqBkeAlleAlleA2lLHw4yObNCPoV_5NCAfo98GQd7P4jNywvVt_-iv8CtzWdfw |
| Cites_doi | 10.1016/j.drudis.2023.103494 10.1039/D2OB01511K 10.1039/C7CS00792B 10.1021/jacs.2c04179 10.1038/s41467-019-12453-6 10.1039/C5SC01681A 10.1039/c39760000734 10.1021/acs.orglett.5b00779 10.1039/B703905K 10.1021/jacs.5b06207 10.1002/9783527652693.ch7 10.1002/chem.201700266 10.1016/j.ccr.2020.213656 10.1021/jacs.3c06301 10.1107/S2052252515024379 10.1021/jacs.5b00534 10.1002/anie.201707097 10.1021/jacs.5b06760 10.1021/cm980600l 10.1021/jm501100b 10.1021/jacs.8b07065 10.1039/D1CS00225B 10.1021/acs.chemrev.0c00672 10.1002/chem.202004375 10.1021/jacs.3c10720 10.1002/ejoc.201700397 10.1002/bscb.19830921107 10.1039/D3CE00216K 10.1107/S2052520616003954 10.1039/c3ra22290j 10.1021/jacs.9b10501 10.1038/s41557-022-01103-y 10.1021/ja512817f 10.1021/acs.joc.9b03429 10.1038/s41467-023-35924-3 |
| ContentType | Journal Article |
| Copyright | 2024 Chemistry Europe 2024 Chemistry Europe. 2024 Wiley-VCH GmbH |
| Copyright_xml | – notice: 2024 Chemistry Europe – notice: 2024 Chemistry Europe. – notice: 2024 Wiley-VCH GmbH |
| DBID | NPM AAYXX CITATION 7SR 8BQ 8FD JG9 K9. 7X8 |
| DOI | 10.1002/chem.202400957 |
| DatabaseName | PubMed CrossRef Engineered Materials Abstracts METADEX Technology Research Database Materials Research Database ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef Materials Research Database ProQuest Health & Medical Complete (Alumni) Engineered Materials Abstracts Technology Research Database METADEX MEDLINE - Academic |
| DatabaseTitleList | Materials Research Database MEDLINE - Academic PubMed CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 1521-3765 |
| EndPage | n/a |
| ExternalDocumentID | 10_1002_chem_202400957 38608156 CHEM202400957 |
| Genre | article Journal Article |
| GrantInformation_xml | – fundername: National Science Foundation funderid: DMR-2002964 – fundername: National Science Foundation grantid: DMR-2002964 |
| GroupedDBID | --- -DZ -~X .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 6J9 702 77Q 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AAXRX AAZKR ABCQN ABCUV ABDBF ABIJN ABJNI ABLJU ABPVW ACAHQ ACCFJ ACCZN ACGFS ACIWK ACNCT ACPOU ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS AMBMR AMYDB ATUGU AUFTA AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM EBS F00 F01 F04 F5P G-S G.N GNP GODZA H.T H.X HBH HGLYW HHY HHZ HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2W P2X P4D PQQKQ Q.N Q11 QB0 QRW R.K RGC RNS ROL RWI RX1 RYL SUPJJ TN5 TWZ UB1 UPT V2E V8K W8V W99 WBFHL WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WRC WXSBR WYISQ XG1 XPP XV2 YZZ ZZTAW ~IA ~WT NPM AAMNL AAYXX CITATION LH4 7SR 8BQ 8FD JG9 K9. 7X8 |
| ID | FETCH-LOGICAL-c3287-8f6f7d6cdbfd6e6582d5d141491b721a0f0f26eee5c8607dfec66dc44ee4a1cc3 |
| IEDL.DBID | DR2 |
| ISSN | 0947-6539 |
| IngestDate | Thu Dec 05 23:44:55 EST 2024 Thu Oct 10 16:12:45 EDT 2024 Fri Dec 06 03:12:42 EST 2024 Sat Nov 02 12:24:43 EDT 2024 Sat Aug 24 00:58:11 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 33 |
| Keywords | Host-guest Hydrogen-Bonded Framework Tautomerization Crystallography Structure Elucidation |
| Language | English |
| License | 2024 Chemistry Europe. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3287-8f6f7d6cdbfd6e6582d5d141491b721a0f0f26eee5c8607dfec66dc44ee4a1cc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2498-1259 0000-0003-3684-4101 0000-0002-1482-388X |
| PMID | 38608156 |
| PQID | 3066837163 |
| PQPubID | 986340 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_3038437798 proquest_journals_3066837163 crossref_primary_10_1002_chem_202400957 pubmed_primary_38608156 wiley_primary_10_1002_chem_202400957_CHEM202400957 |
| PublicationCentury | 2000 |
| PublicationDate | June 12, 2024 |
| PublicationDateYYYYMMDD | 2024-06-12 |
| PublicationDate_xml | – month: 06 year: 2024 text: June 12, 2024 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany – name: Weinheim |
| PublicationSubtitle | A European Journal |
| PublicationTitle | Chemistry : a European journal |
| PublicationTitleAlternate | Chemistry |
| PublicationYear | 2024 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2021; 27 2013; 3 2015; 17 2015; 6 2023; 14 2018; 140 2017; 2017 2020; 85 2023; 15 2020; 120 2019; 10 2023; 145 2017; 23 2007 2016; 72 2022; 20 1983; 92 2021; 50 2019; 141 2018; 47 2022; 144 2023; 25 2016; 3 2015; 137 2023; 28 2017; 56 2014; 57 2016 2021; 430 1976; 18 1998; 10 e_1_2_8_28_2 e_1_2_8_29_2 e_1_2_8_23_2 e_1_2_8_47_1 e_1_2_8_24_2 e_1_2_8_46_1 e_1_2_8_25_2 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_9_2 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_4_2 e_1_2_8_6_2 e_1_2_8_5_2 e_1_2_8_8_2 e_1_2_8_7_2 e_1_2_8_43_1 e_1_2_8_20_2 e_1_2_8_42_1 e_1_2_8_21_2 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_44_1 e_1_2_8_1_1 e_1_2_8_41_1 e_1_2_8_40_1 e_1_2_8_17_2 e_1_2_8_39_1 e_1_2_8_18_2 e_1_2_8_19_1 e_1_2_8_12_2 e_1_2_8_35_2 e_1_2_8_36_1 e_1_2_8_13_2 e_1_2_8_34_2 e_1_2_8_14_2 e_1_2_8_38_1 e_1_2_8_15_2 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_31_2 e_1_2_8_10_1 e_1_2_8_30_2 e_1_2_8_11_2 e_1_2_8_32_2 e_1_2_8_33_1 |
| References_xml | – volume: 144 start-page: 11413 year: 2022 end-page: 11424 publication-title: J. Am. Chem. Soc. – start-page: 183 year: 2016 end-page: 200 publication-title: in Disordered Pharmaceutical Materials – volume: 145 start-page: 17013 year: 2023 end-page: 17017 publication-title: J. Am. Chem. Soc. – volume: 56 start-page: 14003 year: 2017 end-page: 14006 publication-title: Angew. Chem. Int. Ed. – volume: 430 year: 2021 publication-title: Coord. Chem. Rev. – volume: 3 start-page: 139 year: 2016 end-page: 151 publication-title: IUCrJ – volume: 6 start-page: 3765 year: 2015 end-page: 3768 publication-title: Chem. Sci. – volume: 3 start-page: 7427 year: 2013 end-page: 7437 publication-title: RSC Adv. – volume: 137 start-page: 3386 year: 2015 end-page: 3392 publication-title: J. Am. Chem. Soc. – start-page: 2121 year: 2007 end-page: 2123 publication-title: Chem. Commun. – volume: 92 start-page: 965 year: 1983 end-page: 993 publication-title: Bull. Soc. Chim. Belg. – volume: 137 start-page: 12045 year: 2015 end-page: 12049 publication-title: J. Am. Chem. Soc. – volume: 85 start-page: 4706 year: 2020 end-page: 4711 publication-title: J. Org. Chem. – volume: 140 start-page: 12915 year: 2018 end-page: 12921 publication-title: J. Am. Chem. Soc. – volume: 10 start-page: 4477 year: 2019 publication-title: Nat. Commun. – volume: 120 start-page: 13480 year: 2020 end-page: 13544 publication-title: Chem. Rev. – volume: 2017 start-page: 3282 year: 2017 end-page: 3287 publication-title: Eur. J. Org. Chem. – volume: 15 start-page: 405 year: 2023 end-page: 412 publication-title: Nat. Chem. – volume: 72 start-page: 171 year: 2016 end-page: 179 publication-title: Acta Crystallogr. B – volume: 47 start-page: 8525 year: 2018 end-page: 8540 publication-title: Chem. Soc. Rev. – volume: 23 start-page: 4037 year: 2017 end-page: 4041 publication-title: Chem. Eur. J. – volume: 25 start-page: 2845 year: 2023 end-page: 2858 publication-title: CrystEngComm – volume: 137 start-page: 12269 year: 2015 end-page: 12275 publication-title: J. Am. Chem. Soc. – volume: 145 start-page: 25971 year: 2023 end-page: 25975 publication-title: J. Am. Chem. Soc. – volume: 27 start-page: 5344 year: 2021 end-page: 5378 publication-title: Chem. Eur. J. – volume: 28 year: 2023 publication-title: Drug Discov. Today – volume: 50 start-page: 10713 year: 2021 end-page: 10732 publication-title: Chem. Soc. Rev. – volume: 10 start-page: 4159 year: 1998 end-page: 4168 publication-title: Chem. Mater. – volume: 14 start-page: 561 year: 2023 publication-title: Nat. Commun. – volume: 137 start-page: 1794 year: 2015 end-page: 1797 publication-title: J. Am. Chem. Soc. – volume: 17 start-page: 2178 year: 2015 end-page: 2181 publication-title: Org. Lett. – volume: 141 start-page: 18862 year: 2019 end-page: 18869 publication-title: J. Am. Chem. Soc. – volume: 18 start-page: 734 year: 1976 end-page: 736 publication-title: J. Chem. Soc. Chem. Commun. – volume: 57 start-page: 10257 year: 2014 end-page: 10274 publication-title: J. Med. Chem. – volume: 20 start-page: 8259 year: 2022 end-page: 8268 publication-title: Org. Biomol. Chem. – ident: e_1_2_8_20_2 doi: 10.1016/j.drudis.2023.103494 – ident: e_1_2_8_48_1 – ident: e_1_2_8_5_2 doi: 10.1039/D2OB01511K – ident: e_1_2_8_44_1 doi: 10.1039/C7CS00792B – ident: e_1_2_8_45_1 – ident: e_1_2_8_11_2 doi: 10.1021/jacs.2c04179 – ident: e_1_2_8_37_1 doi: 10.1038/s41467-019-12453-6 – ident: e_1_2_8_34_2 doi: 10.1039/C5SC01681A – ident: e_1_2_8_41_1 doi: 10.1039/c39760000734 – ident: e_1_2_8_30_2 doi: 10.1021/acs.orglett.5b00779 – ident: e_1_2_8_18_2 doi: 10.1039/B703905K – ident: e_1_2_8_31_2 doi: 10.1021/jacs.5b06207 – ident: e_1_2_8_21_2 doi: 10.1002/9783527652693.ch7 – ident: e_1_2_8_3_1 – ident: e_1_2_8_42_1 doi: 10.1002/chem.201700266 – ident: e_1_2_8_12_2 doi: 10.1016/j.ccr.2020.213656 – ident: e_1_2_8_22_1 – ident: e_1_2_8_15_2 doi: 10.1021/jacs.3c06301 – ident: e_1_2_8_39_1 – ident: e_1_2_8_35_2 doi: 10.1107/S2052252515024379 – ident: e_1_2_8_43_1 – ident: e_1_2_8_33_1 – ident: e_1_2_8_29_2 doi: 10.1021/jacs.5b00534 – ident: e_1_2_8_40_1 – ident: e_1_2_8_6_2 doi: 10.1002/anie.201707097 – ident: e_1_2_8_9_2 doi: 10.1021/jacs.5b06760 – ident: e_1_2_8_8_2 doi: 10.1021/cm980600l – ident: e_1_2_8_10_1 – ident: e_1_2_8_1_1 doi: 10.1021/jm501100b – ident: e_1_2_8_27_1 – ident: e_1_2_8_16_1 – ident: e_1_2_8_28_2 doi: 10.1021/jacs.8b07065 – ident: e_1_2_8_4_2 doi: 10.1039/D1CS00225B – ident: e_1_2_8_13_2 doi: 10.1021/acs.chemrev.0c00672 – ident: e_1_2_8_19_1 – ident: e_1_2_8_2_1 doi: 10.1002/chem.202004375 – ident: e_1_2_8_14_2 doi: 10.1021/jacs.3c10720 – ident: e_1_2_8_46_1 – ident: e_1_2_8_32_2 doi: 10.1002/ejoc.201700397 – ident: e_1_2_8_47_1 doi: 10.1002/bscb.19830921107 – ident: e_1_2_8_25_2 doi: 10.1039/D3CE00216K – ident: e_1_2_8_38_1 doi: 10.1107/S2052520616003954 – ident: e_1_2_8_26_1 doi: 10.1039/c3ra22290j – ident: e_1_2_8_36_1 doi: 10.1021/jacs.9b10501 – ident: e_1_2_8_7_2 doi: 10.1038/s41557-022-01103-y – ident: e_1_2_8_23_2 doi: 10.1021/ja512817f – ident: e_1_2_8_17_2 doi: 10.1021/acs.joc.9b03429 – ident: e_1_2_8_24_2 doi: 10.1038/s41467-023-35924-3 |
| SSID | ssj0009633 |
| Score | 2.507477 |
| Snippet | Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate (G4PYR) and bis (guanidinium) 1,5‐napthalene disulfonate (G2NDS) to catalyze the... Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate (G PYR) and bis (guanidinium) 1,5-napthalene disulfonate (G NDS) to catalyze the... Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate ( G 4 PYR ) and bis (guanidinium) 1,5‐napthalene disulfonate ( G 2 NDS ) to catalyze... Herein we report the use of tetrakis (guanidinium) pyrenetetrasulfonate (G4PYR) and bis (guanidinium) 1,5-napthalene disulfonate (G2NDS) to catalyze the... |
| SourceID | proquest crossref pubmed wiley |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | e202400957 |
| SubjectTerms | Catalysts Crystallography Encapsulation Host-guest Hydrogen-Bonded Framework Structure Elucidation Tautomerization |
| Title | Formation, Selective Encapsulation, and Tautomerization Control of Isoindolone Utilizing Guanidinium Sulfonate Frameworks |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fchem.202400957 https://www.ncbi.nlm.nih.gov/pubmed/38608156 https://www.proquest.com/docview/3066837163 https://search.proquest.com/docview/3038437798 |
| Volume | 30 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB4hLnDh0UIJpZUrIXHBkE0cxzlWC6ttJTiwrMQtcvyQom6zFZsc2F_fcbwJLByQ2lui2Io9Hs_DnvkG4FRpkSS64FRlllNmwoxm2JRmGePSKl7o9qL95paPp-znQ_LwIovf40P0B25uZ7Ty2m1wWSwun0FDcU4uk9zFQGaJSycfxKmL6bu6e8aPQu7yteRZSh0Ga4faGEaX693XtdIbU3Pdcm1Vz2gXZDdoH3Hy66Kpiwu1fIXn-D-z2oOdlV1KvntG2ocNU32ArWFXDu4jPI26NMdzMmmL56CcJNeVkuhnz1YfZKXJvWzqubsH8gmeZOiD4cnckh-LeVlpFLeVIdO6nJVLVJwEubQqUYWWzW8yaWbWnecbMuqixhYHMB1d3w_HdFW3gaoYHTAqLLep5koXVnODJk6kEz1g6IsNCnQ4ZWhDG3FjTKIED1NtjeJcK8aMYXKgVHwImxWO5AiIQvHCdZRyJhgrNBNSG6RLbMM0E1LEAZx165b_8fAcuQdijnJHyrwnZQAn3bLmq226yNFf4uiho00awLf-MxLW3ZrIyswb1yYWzMEyigA-eXbofxXj-B3cTgBRu6jvjCF3MBf92_G_dPoM2-6ZttWTTmCzfmzMFzSL6uJry_p_ASrgBz4 |
| link.rule.ids | 314,780,784,1375,27924,27925,46294,46718 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BOZRLeUOggJGQuOA2mziOc0RLV1toe6C7ErfI8UOKWLIVmxzor2cm3qRaOCDBMYmt2OOZ8Yw98w3AW2NVltlKclN4yYWLC15gU14UQmpvZGX7i_bzCzlfik9fsyGakHJhAj7EeOBGktHraxJwOpA-vkENxUlRKjkFQRZZfhvuoMxPKKrr45cbBCnkr1BNXuScUFgH3MY4Od7tv7sv_WFs7tqu_eYzuwfVMOwQc_LtqGurI3P9G6Ljf83rPhxsTVP2IfDSA7jlmoewPx0qwj2Cn7Mh0_E9u-zr56CqZCeN0ehqr7YfdGPZQnftmq6CQo4nm4Z4eLb27HSzrhuLGrdxbNnWq_oa906GjNrUuIvW3Xd22a08Hek7NhsCxzaPYTk7WUznfFu6gZsUfTCuvPS5lcZW3kqHVk5iMzsR6I5NKvQ5dexjn0jnXGaUjHPrnZHSGiGcE3piTPoE9hocyTNgBjWMtEkuhRKiskJp65AuqY_zQmmVRvBuWLjyKiB0lAGLOSmJlOVIyggOh3Utt5K6KdFlkuiko1kawZvxMxKWLk5049YdtUmVIGRGFcHTwA_jr1IcPyHuRJD0q_qXMZSEdDE-Pf-XTq9hf744PyvPTi8-v4C79J73xZQOYa_90bmXaCW11ateDn4BpsoLXw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RkFoulD6gaYG6UqVeasgmjuMc0UIEfaCqsBK3yPFDiliyqJsc4Nd3HG8C2x4qlWMSWxmPPS97_A3AR6VFkuiSU5VZTpkJM5phU5pljEureKm7g_bvZ_xkwr5cJpcPbvF7fIhhw81JRqevnYDfaHtwDxqKY3I3yV0OZJakT2CN8Shz6PlHP-8BpHB5-WLyLKUOhLWHbQyjg-X-y2bpL19z2XXtbE_-HGRPtU85udpvm3Jf3f0B6PiYYW3CxsIxJYd-Jb2AFVO_hGfjvh7cK7jN-3uOn8l5Vz0HFSU5rpXEQHu6-CBrTS5k28zcQZC_4UnGPhuezCw5nc-qWqO-rQ2ZNNW0ukPLSXCZ1hXa0Kq9Juft1LoNfUPyPm1s_hom-fHF-IQuCjdQFWMERoXlNtVc6dJqbtDHiXSiRwyDsVGJEacMbWgjboxJlOBhqq1RnGvFmDFMjpSKt2C1RkreAFGoX7iOUs4EY6VmQmqDfIltmGZCijiAT_28FTcen6PwSMxR4VhZDKwMYKef1mIhp_MCAyaOITo6pQF8GD4jY92xiazNrHVtYsEcLqMIYNsvh-FXMdLv8HYCiLpJ_QcNhcO5GJ7e_k-n9_D0x1FefDs9-_oO1t1r2lVS2oHV5ldrdtFFasq9Tgp-A34ACg4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Formation%2C+Selective+Encapsulation%2C+and+Tautomerization+Control+of+Isoindolone+Utilizing+Guanidinium+Sulfonate+Frameworks&rft.jtitle=Chemistry+%3A+a+European+journal&rft.au=Chaudhry%2C+Mohammad+T&rft.au=Newman%2C+Justin+A&rft.au=Lee%2C+Alfred+Y&rft.date=2024-06-12&rft.eissn=1521-3765&rft.spage=e202400957&rft.epage=e202400957&rft_id=info:doi/10.1002%2Fchem.202400957&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0947-6539&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0947-6539&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0947-6539&client=summon |